In­vestors to tap GSK's re­search site for new bil­lion-dol­lar life sci­ences cam­pus — re­port

Two in­vestors, armed with sub­stan­tial fi­nan­cial back­ing, are tak­ing ad­van­tage of 33 acres of land at a Big Phar­ma R&D hub to build a new life sci­ences cam­pus.

A re­port in The Times and retweet­ed by GSK came out ear­ly Mon­day, say­ing that in­vest­ment firm UBS As­set Man­age­ment — a sub­sidiary of Swiss pri­vate mega­bank UBS — has part­nered with prop­er­ty in­vestor Reef Group to in­vest up to £900 mil­lion, or $1.08 bil­lion, to buy up 33 acres of land at one of GSK’s R&D sites, lo­cat­ed in Steve­nage, UK.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER